• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Improve the FDA National Incident Management System (NIMS) Implementation Plan

Description: Enhance response operations through the use of the Incident Command System (ICS) and the application of standardized procedures and preparedness measures which promote cross-jurisdictional agency, statewide, and interstate mechanisms for coordinating response.

Public Health Outcome: The continuation of the FDA NIMS implementation and compliance program will evolve as policy and technical issues are further developed. FDA has proven to have a consistent and strengthened national capability to prevent, prepare for, and respond to any type of incident involving FDA regulated products as required under the National Response Framework.

Accomplishment: Led by the Office of Crisis Management (OCM), an FDA National Incident Management System (NIMS) Implementation Working Group was formed in August 2009 to drive the agency’s efforts to comply with the requirements of NIMS and ongoing initiatives which support the achievement of this goal. FDA invested in a multi-tiered approach for the development and implementation of an effective NIMS Incident Command System (ICS). In order to promote the application of ICS principles within the agency and its federal, state, and local agency partners, FDA, through the Office of Regulatory Affairs (ORA) Division of Human Resource Development, conducted 27 classes of intermediate ICS 300 with a total of 753 personnel trained and 23 classes of advanced ICS 400 with a total of 592 personnel trained since mid-FY2008. Since March 2010, FDA completed 8 sessions of ICS 402, providing an ICS overview for 109 Executives/Senior Officials within the agency. FDA also conducted position-specific classroom training to a total of 105 personnel to serve as Incident Commanders, Operations Section Chiefs, Planning Section Chiefs, Logistics Section Chiefs and Finance/Admin Section Chiefs on Incident Management Teams (IMTs) that will be expected to mobilize/deploy in a response capacity.

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. Establish an FDA NIMS/ICS Implementation Work Group comprised of representatives from OC, ORA and Centers

8/31/2009

Completed 8/6/2009

B. Draft of FDA NIMS/ICS Implementation Plan (1)

8/31/2009

Completed 7/6/2009

C. Develop an FDA specific version of ICS100 - Introduction to Incident Command System

4/30/2010

Completed 4/13/2010

D. Finalization of FDA NIMS/ICS Implementation Plan

5/1/2010

Completed 6/30/2010

E. Develop a NIMS/ICS Training Plan that addresses the training needs of appropriate staff

5/1/2010

Completed 5/26/2010

F. Develop a mechanism to track employees receiving NIMS/ICS training

6/1/2010

Completed 6/1/2010

G. Identify appropriate staff requiring NIMS/ICS training

11/1/2010

Completed 10/28/2010

H. Evaluate and assess the effectiveness of the plans

6/30/2011

Completed 6/29/2011

I. Conduct NIMS/ICS training

10/31/2011

Completed 9/30/2011

Footnotes

  • (1) Latest draft up to date as of January 8, 2010.

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.